Kolexia
Firmin Nelly Oncologie médicale
Firmin Nelly
Oncologie médicale
Icm Montpellier
Montpellier, France
112 Activités
41 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Tumeurs du sein Métastase tumorale Carence en vitamine D Léiomyosarcome Tumeurs du cerveau Tumeurs des tissus mous Tumeurs osseuses Liposarcome

Collaborateurs

Voir plus
Blay Jean Yves
Blay Jean Yves
Centre Léon-Bérard, Lyon, France
Bompas Emmanuelle
Bompas Emmanuelle
Institut de cancérologie de l'Ouest, Saint-Herblain, France
Duffaud Florence
Duffaud Florence
Hôpital La Timone, Marseille, France
Italiano Antoine
Italiano Antoine
Institut Bergonié, Bordeaux, France

Industries

Voir plus
Pfizer
4 collaboration(s)
Dernière en 2023
Lilly
3 collaboration(s)
Dernière en 2023
Pharma Mar
3 collaboration(s)
Dernière en 2023
Novartis
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
CHIC-STS01: Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   26 février 2024
Improved nationwide survival of sarcoma patients with a network of reference centers.
Annals of oncology : official journal of the European Society for Medical Oncology   19 janvier 2024
MEDISARC-SBRT: Phase I Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   12 janvier 2024
Management of oligometastatic/metastatic sarcomas and place of local treatments with focus on modern radiotherapy approaches.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   10 janvier 2024
A 2023 inventory in oncology news.
Bulletin du cancer   05 janvier 2024
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
European journal of cancer (Oxford, England : 1990)   23 novembre 2023
Predictive factors assessment of pathological response to neoadjuvant radiotherapy of soft tissue sarcomas.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   07 octobre 2023
1913O A randomised, multicenter phase-III study comparing doxorubicin (dox) alone versus dox with trabectedin (trab) followed by trab in non-progressive patients (pts) as first-line therapy, in pts with metastatic or unresectable leiomyosarcoma (LMS): Final results of the LMS-04 study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1928P Differential presentation and outcome of sclerosing epithelioid fibrosarcoma (SEF) vs low grade fibromyxoid sarcoma (LGFMS): The nationwide series of 330 patients in NETSARC since 2010
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1927P Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023